Savara Pharmaceuticals
SVRA
#6613
Rank
A$0.79 B
Marketcap
$4.62
Share price
-6.58%
Change (1 day)
-17.87%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -A$0.12 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$84.74 Million a decrease over its 2022 earnings that were of -A$59.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.12 Billion34.44%
2023 -A$84.74 Million43.38%
2022 -A$59.1 Million-11.31%
2021 -A$66.64 Million-13.3%
2020 -A$76.86 Million-36.53%
2019 -A$0.13 Billion13.76%
2018 -A$0.11 Billion105.54%
2017 -A$51.79 Million34.11%
2016 -A$38.62 Million-37.43%
2015 -A$61.72 Million38.81%
2014 -A$44.47 Million33.62%
2013 -A$33.28 Million38.49%
2012 -A$24.03 Million24.59%
2011 -A$19.29 Million-36.5%
2010 -A$30.37 Million-3.14%
2009 -A$31.36 Million-23.28%
2008 -A$40.87 Million8.52%
2007 -A$37.66 Million-34.14%
2006 -A$57.19 Million184.43%
2005 -A$20.11 Million90.75%
2004 -A$10.54 Million190.35%
2003 -A$3.64 Million11.64%
2002 -A$3.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.13 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA